Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

CRISPR/Cas9 Genome Editing01:28

CRISPR/Cas9 Genome Editing

167
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
167
CRISPR01:59

CRISPR

52.7K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.7K
CRISPR and crRNAs02:53

CRISPR and crRNAs

17.3K
Bacteria and archaea are susceptible to viral infections just like eukaryotes; therefore, they have developed a unique adaptive immune system to protect themselves. Clustered regularly interspaced short palindromic repeats and CRISPR-associated proteins (CRISPR-Cas) are present in more than 45% of known bacteria and 90% of known archaea.
The CRISPR-Cas system stores a copy of foreign DNA in the host genome and uses it to identify the foreign DNA upon reinfection. CRISPR-Cas has three different...
17.3K
The Antiviral System of Bacteria and Archaea: CRISPR01:23

The Antiviral System of Bacteria and Archaea: CRISPR

104
CRISPR stands for Clustered Regularly Interspaced Short Palindromic Repeats is a adaptive immune system found in bacteria and archaea that protects against viral infections. This system enables prokaryotic cells to identify, remember, and neutralize foreign genetic elements, primarily bacteriophages, by storing fragments of the invader’s DNA as a genetic memory.The CRISPR immune response begins during an initial infection. Cas (CRISPR-associated) proteins play a central role in this...
104
Homologous Recombination02:31

Homologous Recombination

50.9K
The basic reaction of homologous recombination (HR) involves two chromatids that contain DNA sequences sharing a significant stretch of identity. One of these sequences uses a strand from another as a template to synthesize DNA in an enzyme-catalyzed reaction. The final product is a novel amalgamation of the two substrates. To ensure an accurate recombination of sequences, HR is restricted to the S and G2 phases of the cell cycle. At these stages, the DNA has been replicated already and the...
50.9K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

6.1K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.1K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Craspase Protease Activation Is Sensitive to Oncogenic Single-Nucleotide RNA Mismatches.

ACS chemical biology·2026
Same author

The biology of jumbo phages.

Nature communications·2026
Same author

InstaNovo enables diffusion-powered de novo peptide sequencing in large-scale proteomics experiments.

Nature machine intelligence·2026
Same author

Pre-existing activation states shape functional heterogeneity of human Vγ9Vδ2 T cells.

Frontiers in immunology·2026
Same author

Proteases in bacteriophage defense systems and their potential in bioengineering.

Trends in biochemical sciences·2025
Same author

Reduced prevalence of phage defense systems in <i>Pseudomonas aeruginosa</i> strains from cystic fibrosis patients.

mBio·2025

Related Experiment Video

Updated: Aug 27, 2025

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

827

RNA-targeting CRISPR-Cas systems.

Sam P B van Beljouw1,2, Jasper Sanders3,4, Alicia Rodríguez-Molina3,4

  • 1Department of Bionanoscience, Delft University of Technology, Delft, Netherlands. samvanbeljouw@gmail.com.

Nature Reviews. Microbiology
|September 28, 2022
PubMed
Summary

This review examines how certain bacterial immune systems identify and destroy viral RNA to prevent infection. Unlike systems that target DNA, these mechanisms trigger widespread cellular responses to stop viral spread, providing a unique perspective on microbial defense strategies.

Keywords:
Prokaryotic DefenseCollateral DamageViral TranscriptionAdaptive Immunity

Frequently Asked Questions

More Related Videos

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.5K
Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio
11:27

Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio

Published on: August 28, 2018

22.2K

Related Experiment Videos

Last Updated: Aug 27, 2025

CIRCLE-Seq for Interrogation of Off-Target Gene Editing
08:23

CIRCLE-Seq for Interrogation of Off-Target Gene Editing

Published on: November 1, 2024

827
In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing
10:44

In Vitro Selection of Engineered Transcriptional Repressors for Targeted Epigenetic Silencing

Published on: May 5, 2023

1.5K
Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio
11:27

Efficient Production and Identification of CRISPR/Cas9-generated Gene Knockouts in the Model System Danio rerio

Published on: August 28, 2018

22.2K

Area of Science:

  • Molecular biology of RNA-targeting CRISPR-Cas systems
  • Microbial immunology and host-pathogen interactions

Background:

No prior work had resolved how microbial immunity balances precise detection with extensive cellular damage. It was already known that prokaryotes employ diverse mechanisms to defend against invading genetic elements. Prior research has shown that DNA-cleaving enzymes represent the most common form of adaptive immunity. That uncertainty drove interest in alternative pathways that recognize transcripts rather than genomic material. This gap motivated a deeper look into the unique properties of type III and type VI architectures. Scientists have long debated the evolutionary logic behind non-specific collateral degradation. Such broad responses appear counterintuitive when compared to highly localized enzymatic activity. This review synthesizes current knowledge to clarify how these specialized systems function during active viral challenges.

Purpose Of The Study:

The aim of this review is to summarize the current understanding of RNA-targeting CRISPR-Cas systems. This work addresses the specific problem of how cells manage viral infections that bypass traditional DNA-based defenses. The authors seek to explain the composition and properties of type III and type VI architectures. This study explores the biological rationale behind the broad, collateral effects observed during these immune responses. The motivation stems from the need to understand why prokaryotes employ such destructive strategies. Researchers investigate how sequence-specific detection leads to a system-wide shutdown of cellular processes. The review clarifies the relationship between viral sensing and the subsequent activation of defense pathways. This analysis provides a comprehensive overview of how these mechanisms combat viral infection effectively.

Main Methods:

The review approach involved a comprehensive synthesis of existing literature regarding prokaryotic defense mechanisms. Investigators analyzed structural data to categorize the distinct properties of type III and type VI architectures. The study examined published experimental evidence detailing how these proteins interact with foreign transcripts. Authors evaluated the cellular consequences following the activation of these specialized enzymatic complexes. This review approach integrated findings from various model organisms to establish a unified framework. The team assessed the biological rationale for collateral damage by comparing it to more localized immune responses. Researchers scrutinized peer-reviewed studies to map the sequence of events from initial sensing to final cellular outcomes. This systematic evaluation provided a clear overview of current knowledge in the field.

Main Results:

Key findings from the literature demonstrate that type III and type VI systems utilize sequence-specific recognition to trigger broad, non-specific degradation. The evidence indicates that this collateral activity effectively halts viral replication within the host. Studies show that these systems sense viral transcription products, which allows for the rapid detection of RNA viruses. The literature suggests that the resulting cell-wide damage is a deliberate strategy rather than an accidental byproduct. Findings reveal that these pathways provide a robust defense against diverse invading genetic elements. Data confirm that the composition of these systems allows for high sensitivity to low-abundance viral transcripts. The review highlights that the immune response is tightly regulated to prevent premature activation in the absence of infection. These results collectively support the conclusion that broad-spectrum degradation is an effective evolutionary adaptation for survival.

Conclusions:

The authors suggest that collateral damage serves as a robust barrier against rapidly evolving viral threats. This synthesis and implications review highlights how sensing viral transcripts allows for immediate, system-wide protection. Researchers propose that the broad nature of these responses prevents viral escape mutants from emerging. The evidence indicates that type III and type VI systems operate through distinct, yet functionally convergent, pathways. These findings imply that non-specific degradation is an effective evolutionary trade-off for survival. The authors conclude that these mechanisms provide a flexible defense against diverse RNA-based pathogens. This work clarifies why prokaryotic cells prioritize halting infection over maintaining individual cell viability. The review underscores the necessity of viewing these immune responses as population-level survival strategies.

The researchers propose that these systems detect viral transcripts, which triggers a widespread, non-specific degradation of cellular RNA. This collateral activity halts viral replication by effectively shutting down the host cell's metabolic machinery during an active infection.

Type III and type VI systems are the two primary categories discussed. While both recognize viral transcripts, they differ in their structural composition and the specific enzymatic pathways they activate to initiate the defense response.

The authors note that these systems are necessary for combating RNA viruses. Unlike DNA-targeting systems, these pathways specifically monitor the transcriptome to identify invading genetic material that might otherwise bypass traditional genomic surveillance mechanisms.

The authors describe these systems as acting as sensors that monitor the cellular environment. Once a viral sequence is identified, the system acts as a switch, transitioning the cell from a normal state to an active defense mode.

The researchers measure the effectiveness of these systems by observing the extent of collateral damage. They compare this to the rate of viral clearance, suggesting that extensive degradation correlates with higher survival rates in bacterial populations.

The authors imply that these systems represent a sophisticated evolutionary adaptation. They suggest that the broad, collateral effects are not merely side effects but are instead a deliberate strategy to ensure population-level survival against diverse pathogens.